In silico study of potential immunonutrient-based sports supplements against COVID-19 via targeting ACE2 inhibition using molecular docking and molecular dynamics simulations-Reference-Cited by-同舟云学术

In silico study of potential immunonutrient-based sports supplements against COVID-19 via targeting ACE2 inhibition using molecular docking and molecular dynamics simulations

Published:2021-12-21 Issue: Volume: Page:1-21
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Banitalebi Ebrahim¹,Abdizadeh Tooba²,Khademi Dehkordi Maryam³,Saghaei Elham⁴⁵,Mardaniyan Ghahfarrokhi Majid¹

Affiliation:

1. Department of Sport Sciences, Shahrekord University, Shahrekord, Iran

2. Clinical Biochemistry Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran

3. Falavarjan Branch, Islamic Azad University, Falavarjan, Isfahan, Iran

4. Physiology and Pharmacology Department, School of medicine, Shahrekord University of medical sciences, Shahrekord, Iran

5. Medical plants research center, Basic health science, Shahrekord University of medical sciences, Shahrekord, Iran

Funder

Shahrekord University

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2021.2016489

Reference77 articles.

1. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers

2. Inhibition of Angiotensin Converting Enzyme Activity by Flavanol-Rich Foods

3. Quercetin: Antiviral Significance and Possible COVID-19 Integrative Considerations

4. Common Sports-Related Infections: A Review on Clinical Pictures, Management and Time to Return to Sports

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis;Frontiers in Immunology;2022-06-27